- Home
- ZCMD vs CLNN Comparison
ZCMD vs CLNN Comparison
Compare ZCMD & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZCMD
- CLNN
- Stock Information
- Founded
- ZCMD 2012
- CLNN 2012
- Country
- ZCMD China
- CLNN United States
- Employees
- ZCMD N/A
- CLNN N/A
- Industry
- ZCMD Other Consumer Services
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- ZCMD Real Estate
- CLNN Health Care
- Exchange
- ZCMD Nasdaq
- CLNN Nasdaq
- Market Cap
- ZCMD 30.3M
- CLNN 26.1M
- IPO Year
- ZCMD 2020
- CLNN N/A
- Fundamental
- Price
- ZCMD $1.08
- CLNN $2.83
- Analyst Decision
- ZCMD
- CLNN Strong Buy
- Analyst Count
- ZCMD 0
- CLNN 5
- Target Price
- ZCMD N/A
- CLNN $50.20
- AVG Volume (30 Days)
- ZCMD 3.8K
- CLNN 51.0K
- Earning Date
- ZCMD 01-01-0001
- CLNN 05-07-2025
- Dividend Yield
- ZCMD N/A
- CLNN N/A
- EPS Growth
- ZCMD N/A
- CLNN N/A
- EPS
- ZCMD N/A
- CLNN N/A
- Revenue
- ZCMD $17,406,104.00
- CLNN $342,000.00
- Revenue This Year
- ZCMD N/A
- CLNN N/A
- Revenue Next Year
- ZCMD N/A
- CLNN $2,066.67
- P/E Ratio
- ZCMD N/A
- CLNN N/A
- Revenue Growth
- ZCMD 1.01
- CLNN N/A
- 52 Week Low
- ZCMD $1.00
- CLNN $2.57
- 52 Week High
- ZCMD $2.97
- CLNN $9.20
- Technical
- Relative Strength Index (RSI)
- ZCMD 31.22
- CLNN 34.63
- Support Level
- ZCMD $1.10
- CLNN $2.76
- Resistance Level
- ZCMD $1.28
- CLNN $3.18
- Average True Range (ATR)
- ZCMD 0.08
- CLNN 0.25
- MACD
- ZCMD -0.02
- CLNN 0.05
- Stochastic Oscillator
- ZCMD 0.00
- CLNN 38.33
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is a Cayman Islands-based provider of healthcare information, education, and training services. It provides services to healthcare professionals and the public in China. It offers online and onsite health information services, healthcare education programs, and healthcare training products, consisting of clinical practice training, open classes of popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.